American Century Companies’s Usana Health Sciences USNA Stock Holding History

American Century Companies’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.34M	Sell	190,952 -19,032	-9%	-$378K	﹤0.01%	1939
2025 Q4	$4.12M	Sell	209,984 -50,576	-19%	-$1.05M	﹤0.01%	1815
2025 Q3	$7.18M	Buy	260,560 +5,531	+2%	+$170K	﹤0.01%	1561
2025 Q2	$7.79M	Sell	255,029 -213	-0.1%	-$6.05K	﹤0.01%	1474
2025 Q1	$6.88M	Buy	255,242 +21,445	+9%	+$679K	﹤0.01%	1473
2024 Q4	$8.39M	Buy	233,797 +25,522	+12%	+$954K	﹤0.01%	1408
2024 Q3	$7.9M	Buy	208,275 +48,493	+30%	+$1.99M	﹤0.01%	1402
2024 Q2	$7.23M	Buy	159,782 +17,460	+12%	+$803K	﹤0.01%	1376
2024 Q1	$6.9M	Buy	142,322 +4,212	+3%	+$206K	﹤0.01%	1347
2023 Q4	$7.4M	Buy	138,110 +2,114	+2%	+$107K	0.01%	1272
2023 Q3	$7.97M	Buy	135,996 +3,028	+2%	+$189K	0.01%	1156
2023 Q2	$8.38M	Buy	132,968 +20,550	+18%	+$1.31M	0.01%	1126
2023 Q1	$7.02M	Buy	112,418 +21,972	+24%	+$1.31M	0.01%	1131
2022 Q4	$4.81M	Buy	90,446 +7,555	+9%	+$409K	﹤0.01%	1238
2022 Q3	$4.65M	Buy	82,891 +10,086	+14%	+$667K	﹤0.01%	1146
2022 Q2	$5.27M	Buy	72,805 +21,652	+42%	+$1.61M	﹤0.01%	1101
2022 Q1	$4.06M	Buy	51,153 +2,108	+4%	+$190K	﹤0.01%	1165
2021 Q4	$4.96M	Buy	49,045 +16,701	+52%	+$1.67M	﹤0.01%	1061
2021 Q3	$2.98M	Buy	32,344 +5,759	+22%	+$554K	﹤0.01%	1170
2021 Q2	$2.72M	Sell	26,585 -3,315	-11%	-$333K	﹤0.01%	1147
2021 Q1	$2.92M	Buy	29,900 +2,709	+10%	+$247K	﹤0.01%	1060
2020 Q4	$2.1M	Buy	27,191 +7,897	+41%	+$611K	﹤0.01%	1067
2020 Q3	$1.42M	Sell	19,294 -1,367	-7%	-$110K	﹤0.01%	1047
2020 Q2	$1.52M	Sell	20,661 -21,513	-51%	-$1.69M	﹤0.01%	981
2020 Q1	$2.44M	Buy	+42,174	New	+$2.93M	﹤0.01%	821
2019 Q4	–	Sell	-4,953	Closed	-$339K	–	1562
2019 Q3	$339K	Sell	4,953 -880	-15%	-$59.1K	﹤0.01%	1134
2019 Q2	$463K	Sell	5,833 -95,499	-94%	-$7.57M	﹤0.01%	1148
2019 Q1	$8.5M	Buy	+101,332	New	+$10.6M	0.01%	660
2018 Q4	–	Sell	-12,061	Closed	-$1.45M	–	1347
2018 Q3	$1.45M	Buy	+12,061	New	+$1.5M	﹤0.01%	1066
2016 Q2	–	Sell	-59,720	Closed	-$3.63M	–	1398
2016 Q1	$3.63M	Sell	59,720 -32,728	-35%	-$1.93M	﹤0.01%	893
2015 Q4	$5.91M	Buy	+92,448	New	+$6M	0.01%	784
2014 Q3	–	Sell	-147,802	Closed	-$5.78M	–	1498
2014 Q2	$5.78M	Buy	147,802 +230	+0.2%	+$8.54K	0.01%	848
2014 Q1	$5.56M	Sell	147,572 -36,824	-20%	-$1.29M	0.01%	880
2013 Q4	$6.97M	Buy	184,396 +18,022	+11%	+$690K	0.01%	821
2013 Q3	$7.22M	Sell	166,374 -9,298	-5%	-$373K	0.01%	789
2013 Q2	$6.36M	Buy	+175,672	New	+$5.34M	0.01%	782

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's USNA Position: Q1 2026 in Review

American Century Companies reduced its Usana Health Sciences (USNA) stake by 9.1% in Q1 2026, selling an estimated $378K and leaving 190,952 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

American Century Companies first reported a position in USNA in Q2 2013 and has held it in 36 quarters since. The position peaked at $8.5M in Q1 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

American Century Companies held 190,952 shares of Usana Health Sciences worth $3.34M as of Q1 2026.
American Century Companies sold 19,032 Usana Health Sciences shares in Q1 2026, an estimated $378K.
Usana Health Sciences made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1939 holding.
American Century Companies first reported a position in Usana Health Sciences in Q2 2013 and has held it in 36 quarters since.
American Century Companies's Usana Health Sciences position peaked at $8.5M in Q1 2019.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.